{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:36:30Z","timestamp":1792773390932,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) represents the most abundant mRNA modification, yet its role in natural killer (NK) cell development remains incompletely understood. Here we demonstrate that the m\n                    <jats:sup>6<\/jats:sup>\n                    A methyltransferase METTL14 plays an indispensable, stage-specific role in early NK cell development.\n                    <jats:italic>Mettl14<\/jats:italic>\n                    deficiency at the progenitor stage caused severe NK cell lymphopenia by disrupting the NK progenitor to immature NK cell transition. Paradoxically, residual\n                    <jats:italic>Mettl14<\/jats:italic>\n                    -null NK cells exhibited a hypermetabolic state characterized by mTORC1 hyperactivation and enhanced mitochondrial function, which drove both hyperproliferation and activation-induced cell death via p53 and apoptotic pathway activation. Despite developmental defects, these cells demonstrated superior capacity to control melanoma metastasis in vivo. Mechanistically, METTL14 fine-tuned IL-15 responsiveness likely by sustaining SOCS3 expression to restrain JAK-STAT5 signaling. Terminal deletion of\n                    <jats:italic>Mettl14<\/jats:italic>\n                    produced no phenotype, underscoring its specific requirement during early development. Our findings establish METTL14 as a crucial checkpoint coordinating transcriptional and metabolic programs to ensure NK cell homeostasis.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09069-2","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:38:07Z","timestamp":1785242287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["METTL14-mediated m6A methylation orchestrates early NK cell development by maintaining metabolic fitness"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-0107","authenticated-orcid":false,"given":"Huan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yirong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9035-3429","authenticated-orcid":false,"given":"Chen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0974-5249","authenticated-orcid":false,"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2155-231X","authenticated-orcid":false,"given":"Zhongjun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6067-3966","authenticated-orcid":false,"given":"Shasha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"9069_CR1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nri911","volume":"2","author":"JA Trapani","year":"2002","unstructured":"Trapani JA, Smyth MJ. Functional significance of the perforin\/granzyme cell death pathway. Nat Rev Immunol. 2002;2:735\u2013747.","journal-title":"Nat Rev Immunol"},{"key":"9069_CR2","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1084\/jem.20181454","volume":"216","author":"I Prager","year":"2019","unstructured":"Prager I, Liesche C, van Ooijen H, Urlaub D, Verron Q, Sandstr\u00f6m N, et al. NK cells switch from granzyme B to death receptor\u2013mediated cytotoxicity during serial killing. J Exp Med. 2019;216:2113\u201327.","journal-title":"J Exp Med"},{"key":"9069_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.1198687","volume":"331","author":"E Vivier","year":"2011","unstructured":"Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells. Science. 2011;331:44\u201349.","journal-title":"Science"},{"key":"9069_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","volume":"34","author":"J Yu","year":"2013","unstructured":"Yu J, Freud AG, Caligiuri MA. Location and cellular stages of natural killer cell development. Trends Immunol. 2013;34:573\u201382.","journal-title":"Trends Immunol"},{"key":"9069_CR5","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/ni.2936","volume":"15","author":"A Mar\u00e7ais","year":"2014","unstructured":"Mar\u00e7ais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, et al. The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells. Nat Immunol. 2014;15:749\u201357.","journal-title":"Nat Immunol"},{"key":"9069_CR6","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.it.2022.08.004","volume":"43","author":"S Ma","year":"2022","unstructured":"Ma S, Caligiuri MA, Yu J. Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy. Trends Immunol. 2022;43:833\u201347.","journal-title":"Trends Immunol"},{"key":"9069_CR7","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1084\/jem.20141703","volume":"212","author":"MX Yang","year":"2015","unstructured":"Yang MX, Li D, Chang Z, Yang ZZ, Tian ZG, Dong ZJ. PDK1 orchestrates early NK cell development through induction of E4BP4 expression and maintenance of IL-15 responsiveness. J Exp Med. 2015;212:253\u201365.","journal-title":"J Exp Med"},{"key":"9069_CR8","doi-asserted-by":"crossref","unstructured":"Wang X, Zhao X-Y. Transcription factors associated with IL-15 cytokine signaling during NK cell development. Front Immunol. 2021;12:610789.","DOI":"10.3389\/fimmu.2021.610789"},{"key":"9069_CR9","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.immuni.2012.04.006","volume":"36","author":"K Ramirez","year":"2012","unstructured":"Ramirez K, Chandler KatherineJ, Spaulding C, Zandi S, Sigvardsson M, Graves BarbaraJ, et al. Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity. 2012;36:921\u201332.","journal-title":"Immunity"},{"key":"9069_CR10","doi-asserted-by":"crossref","unstructured":"Liu J, Wang Z, Hao S, Wang F, Yao Y, Zhang Y, et al. Tcf1 sustains the expression of multiple regulators in promoting early natural killer cell development. Front Immunol. 2021;12:791220.","DOI":"10.3389\/fimmu.2021.791220"},{"key":"9069_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.immuni.2011.11.016","volume":"36","author":"ScottM Gordon","year":"2012","unstructured":"Gordon ScottM, Chaix J, Rupp LeviJ, Wu J, Madera S, Sun JosephC, et al. The transcription factors T-bet and eomes control key checkpoints of natural killer cell maturation. Immunity. 2012;36:55\u201367.","journal-title":"Immunity"},{"key":"9069_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/ni.1930","volume":"11","author":"P Aliahmad","year":"2010","unstructured":"Aliahmad P, de la Torre B, Kaye J. Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue\u2013inducer cell and NK cell lineages. Nat Immunol. 2010;11:945\u201352.","journal-title":"Nat Immunol"},{"key":"9069_CR13","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.immuni.2007.04.010","volume":"26","author":"TA Fehniger","year":"2007","unstructured":"Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, French AnthonyR, et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007;26:798\u2013811.","journal-title":"Immunity"},{"key":"9069_CR14","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1084\/jem.20030630","volume":"198","author":"DB Stetson","year":"2003","unstructured":"Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang Z-E, Gapin L, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med. 2003;198:1069\u201376.","journal-title":"J Exp Med"},{"key":"9069_CR15","doi-asserted-by":"crossref","unstructured":"Kim T-D, Park JY, Choi I. Post-transcriptional regulation of NK cell activation. Immune Netw. 2009;9:115\u2013121.","DOI":"10.4110\/in.2009.9.4.115"},{"key":"9069_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev-immunol-101921-045401","volume":"41","author":"D Han","year":"2023","unstructured":"Han D, Xu MM. RNA modification in the immune system. Annu Rev Immunol. 2023;41:73\u201398.","journal-title":"Annu Rev Immunol"},{"key":"9069_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2013","unstructured":"Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A METTL3\u2013METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2013;10:93\u201395.","journal-title":"Nat Chem Biol"},{"key":"9069_CR18","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20:608\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9069_CR19","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41556-019-0318-1","volume":"21","author":"H Lee","year":"2019","unstructured":"Lee H, Bao S, Qian Y, Geula S, Leslie J, Zhang C, et al. Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation. Nat Cell Biol. 2019;21:700\u20139.","journal-title":"Nat Cell Biol"},{"key":"9069_CR20","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ccell.2021.04.016","volume":"39","author":"L Dong","year":"2021","unstructured":"Dong L, Chen C, Zhang Y, Guo P, Wang Z, Li J, et al. The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. Cancer Cell. 2021;39:945\u2013.e910.","journal-title":"Cancer Cell"},{"key":"9069_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"H-B Li","year":"2017","unstructured":"Li H-B, Tong J, Zhu S, Batista PJ, Duffy EE, Zhao J, et al. m6A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature. 2017;548:338\u201342.","journal-title":"Nature"},{"key":"9069_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","volume":"28","author":"J Tong","year":"2018","unstructured":"Tong J, Cao G, Zhang T, Sefik E, Amezcua Vesely MC, Broughton JP, et al. m6A mRNA methylation sustains Treg suppressive functions. Cell Res. 2018;28:253\u20136.","journal-title":"Cell Res"},{"key":"9069_CR23","doi-asserted-by":"crossref","unstructured":"Yao Y, Yang Y, Guo W, Xu L, You M, Zhang Y-C, et al. METTL3-dependent m6A modification programs T follicular helper cell differentiation. Nat Commun. 2021;12:1333.","DOI":"10.1038\/s41467-021-21594-6"},{"key":"9069_CR24","doi-asserted-by":"crossref","unstructured":"Xiao Z, Wang S, Tian Y, Lv W, Sheng H, Zhan M, et al. METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate \u03b3\u03b4 T1 and \u03b3\u03b4 T17 cells. Cell Rep. 2023;42:112684.","DOI":"10.1016\/j.celrep.2023.112684"},{"key":"9069_CR25","doi-asserted-by":"crossref","unstructured":"Song H, Song J, Cheng M, Zheng M, Wang T, Tian S, et al. METTL3-mediated m6A RNA methylation promotes the anti-tumour immunity of natural killer cells. Nat Commun. 2021;12:5522.","DOI":"10.1038\/s41467-021-25803-0"},{"key":"9069_CR26","doi-asserted-by":"crossref","unstructured":"Wang H, Hu X, Huang M, Liu J, Gu Y, Ma L, et al. Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation. Nat Commun. 2019;10:1898.","DOI":"10.1038\/s41467-019-09903-6"},{"key":"9069_CR27","doi-asserted-by":"crossref","unstructured":"Cao L, Morgun E, Genardi S, Visvabharathy L, Cui Y, Huang H, et al. METTL14-dependent m6A modification controls iNKT cell development and function. Cell Rep. 2022;40:111156.","DOI":"10.1016\/j.celrep.2022.111156"},{"key":"9069_CR28","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, et al. The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med. 2017;23:1369\u201376.","journal-title":"Nat Med"},{"key":"9069_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han D, Liu J, Chen C, Dong L, Liu Y, Chang R, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells. Nature. 2019;566:270\u20134.","journal-title":"Nature"},{"key":"9069_CR30","doi-asserted-by":"crossref","unstructured":"Zheng Z, Zhang L, Cui X-L, Yu X, Hsu PJ, Lyu R, et al. Control of early B cell development by the RNA N6-methyladenosine methylation. Cell Rep. 2020;31.","DOI":"10.1016\/j.celrep.2020.107819"},{"key":"9069_CR31","doi-asserted-by":"crossref","unstructured":"Kim SM, Oh SC, Lee SY, Kong LZ, Lee JH, Kim TD. FTO negatively regulates the cytotoxic activity of natural killer cells. EMBO Rep. 2023;24.","DOI":"10.15252\/embr.202255681"},{"key":"9069_CR32","doi-asserted-by":"crossref","unstructured":"Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang L-S, et al. The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. J Exp Med. 2021;218:e20210279.","DOI":"10.1084\/jem.20210279"},{"key":"9069_CR33","doi-asserted-by":"crossref","unstructured":"Chen SS, Li ZH, Feng J, Quan YH, He JM, Hao JQ, et al. Dual activity of type III PI3K kinase Vps34 is critical for NK cell development and senescence. Adv Sci. 2024;11:e2309315.","DOI":"10.1002\/advs.202309315"},{"key":"9069_CR34","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1182\/blood-2008-10-187179","volume":"113","author":"L Chiossone","year":"2009","unstructured":"Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood. 2009;113:5488\u201396.","journal-title":"Blood"},{"key":"9069_CR35","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/s41556-018-0124-1","volume":"20","author":"JB Spinelli","year":"2018","unstructured":"Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol. 2018;20:745\u201354.","journal-title":"Nat Cell Biol"},{"key":"9069_CR36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.cmet.2013.10.001","volume":"18","author":"M Morita","year":"2013","unstructured":"Morita M, Gravel S-P, Ch\u00e9nard V, Sikstr\u00f6m K, Zheng L, Alain T, et al. mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation. Cell Metab. 2013;18:698\u2013711.","journal-title":"Cell Metab"},{"key":"9069_CR37","doi-asserted-by":"publisher","first-page":"17409","DOI":"10.1073\/pnas.1904125116","volume":"116","author":"XF Wang","year":"2019","unstructured":"Wang XF, Sun R, Hao XL, Lian ZX, Wei HM, Tian ZG. IL-17 constrains natural killer cell activity by restraining IL-15-driven cell maturation via SOCS3. Proc Natl Acad Sci USA. 2019;116:17409\u201318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9069_CR38","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41423-023-01071-4","volume":"20","author":"AU Khan","year":"2023","unstructured":"Khan AU, Ali AK, Marr B, Jo D, Ahmadvand S, Fong-McMaster C, et al. The TNF\u03b1\/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis. Cell Mol Immunol. 2023;20:1140\u201355.","journal-title":"Cell Mol Immunol"},{"key":"9069_CR39","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1159\/000448077","volume":"8","author":"W Almishri","year":"2016","unstructured":"Almishri W, Santodomingo-Garzon T, Le T, Stack D, Mody CH, Swain MG. TNF\u03b1 augments cytokine-induced NK cell IFN\u03b3 production through TNFR2. J Innate Immun. 2016;8:617\u201329.","journal-title":"J Innate Immun"},{"key":"9069_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3834","volume":"15","author":"D Brenner","year":"2015","unstructured":"Brenner D, Blaser H, Mak TW. Regulation of tumour necrosis factor signalling: live or let die. Nat Rev Immunol. 2015;15:362\u201374.","journal-title":"Nat Rev Immunol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09069-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09069-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T15:02:30Z","timestamp":1792767750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09069-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9069"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09069-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"18 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"905"}}